These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 31250374)
21. Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population. Sattarifard H; Hashemi M; Hassanzarei S; Basiri A; Narouie B; Ghavami S Nucleosides Nucleotides Nucleic Acids; 2019; 38(1):1-11. PubMed ID: 30587086 [TBL] [Abstract][Full Text] [Related]
22. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India. Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964 [TBL] [Abstract][Full Text] [Related]
23. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer. Wang Y; Wu S; Yang X; Li X; Chen R Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902880 [TBL] [Abstract][Full Text] [Related]
24. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357 [TBL] [Abstract][Full Text] [Related]
25. The Ghapanchi J; Ranjbar Z; Mokhtari MJ; Koohpeima F; Derakhshan M; Khademi B; Ghaderi H; Sheikhbahaei S; Aliabadi E Biomed Res Int; 2020; 2020():1634252. PubMed ID: 32337223 [TBL] [Abstract][Full Text] [Related]
26. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence. Zhang S; Zhong G; He W; Yu H; Huang J; Lin T J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320 [TBL] [Abstract][Full Text] [Related]
27. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke. Zheng Z; Liu S; Wang C; Han X J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169 [TBL] [Abstract][Full Text] [Related]
28. The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population. Lin Y; Ge Y; Wang Y; Ma G; Wang X; Liu H; Wang M; Zhang Z; Chu H Gene; 2017 Sep; 627():226-232. PubMed ID: 28627442 [TBL] [Abstract][Full Text] [Related]
29. Analysis of clinical important of LncRNA-HOTAIR gene variations and ovarian cancer susceptibility. Saeedi N; Ghorbian S Mol Biol Rep; 2020 Oct; 47(10):7421-7427. PubMed ID: 32901358 [TBL] [Abstract][Full Text] [Related]
30. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Yang C; Tang R; Ma X; Wang Y; Luo D; Xu Z; Zhu Y; Yang L Oncotarget; 2015 Jun; 6(17):15311-20. PubMed ID: 25944697 [TBL] [Abstract][Full Text] [Related]
31. The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer. Santos LE; Guilhen AC; de Andrade RA; Sumi LG; Ward LS Urol Oncol; 2011; 29(3):291-4. PubMed ID: 19523860 [TBL] [Abstract][Full Text] [Related]
32. Genetic variants within ANRIL (antisense non coding RNA in the INK4 locus) are associated with risk of psoriasis. Rakhshan A; Zarrinpour N; Moradi A; Ahadi M; Omrani MD; Ghafouri-Fard S; Taheri M Int Immunopharmacol; 2020 Jan; 78():106053. PubMed ID: 31812071 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms. Williams SB; Ye Y; Huang M; Chang DW; Kamat AM; Pu X; Dinney CP; Wu X Cancer Prev Res (Phila); 2015 Jul; 8(7):607-13. PubMed ID: 25896234 [TBL] [Abstract][Full Text] [Related]
35. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis. Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171 [TBL] [Abstract][Full Text] [Related]
36. Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer. Wu L; Chaffee KG; Parker AS; Sicotte H; Petersen GM Tumour Biol; 2015 Sep; 36(10):7431-7. PubMed ID: 25900876 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Figueroa JD; Malats N; Rothman N; Real FX; Silverman D; Kogevinas M; Chanock S; Yeager M; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; García-Closas M Carcinogenesis; 2007 Aug; 28(8):1788-93. PubMed ID: 17557904 [TBL] [Abstract][Full Text] [Related]
38. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A. Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406 [TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma. Zhang H; Guo Y; Song Y; Shang C Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359 [TBL] [Abstract][Full Text] [Related]
40. Genetic variants in lncRNA SRA and risk of breast cancer. Yan R; Wang K; Peng R; Wang S; Cao J; Wang P; Song C Oncotarget; 2016 Apr; 7(16):22486-96. PubMed ID: 26967566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]